Literature DB >> 33144431

Expression of Periostin in Mammary Cancer Cells of Female Dogs.

Paulina Borecka1, Rafal Ciaputa2, Izabela Janus2, Joanna Bubak2, Aleksandra Piotrowska3, Katarzyna Ratajczak-Wielgomas3, Marzenna Podhorska-OkolÓw4, Piotr DziĘgiel3,5, Marcin Nowak2.   

Abstract

BACKGROUND/AIM: Periostin (POSTN) has a significant role in proliferation and migration of tumour cells as well as tumour progression. This study aimed to determinate POSTN expression in cancer cells in malignant and benign tumours of the mammary gland in female dogs.
MATERIALS AND METHODS: All together 83 cancers, 24 adenomas and 7 unchanged fragments of the mammary glands of bitches were investigated. Immunohistochemistry was performed using anti-POSTN, Ki-67 and HER2 antibodies.
RESULTS: POSTN expression was observed in cancer cells in 31.3% of malignancies and 12.5% of benign tumours. A significantly positive correlation between expression of POSTN in cancer cells and the degree of histological malignancy, expression of Ki-67 antigen and expression of POSTN in CAFs was found.
CONCLUSION: The obtained results suggest the possible participation of POSTN in the process of carcinogenesis and progression of mammary tumors in bitches. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Periostin; adenoma; bitches; carcinoma; dog

Mesh:

Year:  2020        PMID: 33144431      PMCID: PMC7811614          DOI: 10.21873/invivo.12162

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  39 in total

Review 1.  Tumor-host interactions: a far-reaching relationship.

Authors:  Sandra S McAllister; Robert A Weinberg
Journal:  J Clin Oncol       Date:  2010-07-19       Impact factor: 44.544

2.  Expression of Periostin in Cancer-associated Fibroblasts in Mammary Cancer in Female Dogs.

Authors:  Paulina Borecka; Katarzyna Ratajczak-Wielgomas; Rafal Ciaputa; Małgorzata Kandefer-Gola; Izabela Janus; Aleksandra Piotrowska; Alicja Kmiecik; Marzena Podhorska-Okolów; Piotr Dzięgiel; Marcin Nowak
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

3.  Periostin expression in cancer-associated fibroblasts of invasive ductal breast carcinoma.

Authors:  Katarzyna Ratajczak-Wielgomas; Jedrzej Grzegrzolka; Aleksandra Piotrowska; Agnieszka Gomulkiewicz; Wojciech Witkiewicz; Piotr Dziegiel
Journal:  Oncol Rep       Date:  2016-09-15       Impact factor: 3.906

Review 4.  Periostin: a novel prognostic and therapeutic target for genitourinary cancer?

Authors:  Pier Vitale Nuzzo; Giulia Buzzatti; Francesco Ricci; Alessandra Rubagotti; Francesca Argellati; Linda Zinoli; Francesco Boccardo
Journal:  Clin Genitourin Cancer       Date:  2014-02-21       Impact factor: 2.872

Review 5.  The role of periostin in neoplastic processes.

Authors:  Katarzyna Ratajczak-Wielgomas; Piotr Dziegiel
Journal:  Folia Histochem Cytobiol       Date:  2015-07-07       Impact factor: 1.698

Review 6.  Canine mammary tumors as a model for human disease.

Authors:  Somaia M Abdelmegeed; Sulma Mohammed
Journal:  Oncol Lett       Date:  2018-04-02       Impact factor: 2.967

7.  Periostin shows increased evolutionary plasticity in its alternatively spliced region.

Authors:  Sebastian Hoersch; Miguel A Andrade-Navarro
Journal:  BMC Evol Biol       Date:  2010-01-28       Impact factor: 3.260

8.  Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.

Authors:  Antonio C Wolff; M Elizabeth H Hammond; David G Hicks; Mitch Dowsett; Lisa M McShane; Kimberly H Allison; Donald C Allred; John M S Bartlett; Michael Bilous; Patrick Fitzgibbons; Wedad Hanna; Robert B Jenkins; Pamela B Mangu; Soonmyung Paik; Edith A Perez; Michael F Press; Patricia A Spears; Gail H Vance; Giuseppe Viale; Daniel F Hayes
Journal:  J Clin Oncol       Date:  2013-10-07       Impact factor: 44.544

9.  Identification of prognostic factors in canine mammary malignant tumours: a multivariable survival study.

Authors:  Andreia A Santos; Célia C Lopes; Jorge R Ribeiro; Liliana R Martins; Joana C Santos; Irina F Amorim; Fátima Gärtner; Augusto J Matos
Journal:  BMC Vet Res       Date:  2013-01-04       Impact factor: 2.741

10.  Differential stromal reprogramming in benign and malignant naturally occurring canine mammary tumours identifies disease-modulating stromal components.

Authors:  Parisa Amini; Sina Nassiri; Alexandra Malbon; Enni Markkanen
Journal:  Sci Rep       Date:  2020-03-26       Impact factor: 4.379

View more
  1 in total

Review 1.  The Role of Periostin in Angiogenesis and Lymphangiogenesis in Tumors.

Authors:  Adrian Wasik; Katarzyna Ratajczak-Wielgomas; Arkadiusz Badzinski; Piotr Dziegiel; Marzenna Podhorska-Okolow
Journal:  Cancers (Basel)       Date:  2022-08-30       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.